FDA inspection
Reliance Life Sciences Private Limited: FDA inspection ending Apr 15, 2022
FDA inspection 1170339 · No Action Indicated (NAI) · Navi Mumbai
Key facts
| Inspection ID | 1170339 |
|---|---|
| Firm | Reliance Life Sciences Private Limited |
| FEI number | 3009510975 |
| Address | Dhirubhai Ambani Life Sciences Centre, R-282, TTC Area of MIDC, Thane-Belapur Road |
| City | Navi Mumbai |
| Country | India |
| Fiscal year | 2022 |
| Inspection end date | Apr 15, 2022 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data